These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 26804943

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of the effect of a 0.0584% hydrocortisone aceponate spray on clinical signs and skin barrier function in dogs with atopic dermatitis.
    Nam EH, Park SH, Jung JY, Han SH, Youn HY, Chae JS, Hwang CY.
    J Vet Sci; 2012 Jun; 13(2):187-91. PubMed ID: 22705741
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Therapeutic efficacy of topical hydrocortisone aceponate in experimental flea-allergy dermatitis in dogs.
    Bonneau S, Skowronski V, Sanquer A, Maynard L, Eun HM.
    Aust Vet J; 2009 Jul; 87(7):287-91. PubMed ID: 19573156
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomized, double-blinded, placebo-controlled pilot study on the effects of topical blackcurrant emulsion enriched in essential fatty acids, ceramides and 18-beta glycyrrhetinic acid on clinical signs and skin barrier function in dogs with atopic dermatitis.
    Marsella R, Cornegliani L, Ozmen I, Bohannon M, Ahrens K, Santoro D.
    Vet Dermatol; 2017 Dec; 28(6):577-e140. PubMed ID: 28736984
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
    Michels GM, Ramsey DS, Walsh KF, Martinon OM, Mahabir SP, Hoevers JD, Walters RR, Dunham SA.
    Vet Dermatol; 2016 Dec; 27(6):478-e129. PubMed ID: 27647569
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
    Little PR, King VL, Davis KR, Cosgrove SB, Stegemann MR.
    Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
    [Abstract] [Full Text] [Related]

  • 15. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, Yi D, Zhao B.
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [Abstract] [Full Text] [Related]

  • 16. The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study.
    Carlotti DN, Boulet M, Ducret J, Machicote G, Jasmin P, Rème CA, Albouy M.
    Vet Dermatol; 2009 Oct; 20(5-6):405-11. PubMed ID: 20178477
    [Abstract] [Full Text] [Related]

  • 17. A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis.
    Michels GM, Walsh KF, Kryda KA, Mahabir SP, Walters RR, Hoevers JD, Martinon OM.
    Vet Dermatol; 2016 Dec; 27(6):505-e136. PubMed ID: 27647513
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D shows in vivo efficacy in a placebo-controlled, double-blinded, randomised clinical trial on canine atopic dermatitis.
    Klinger CJ, Hobi S, Johansen C, Koch HJ, Weber K, Mueller RS.
    Vet Rec; 2018 Apr 07; 182(14):406. PubMed ID: 29419484
    [Abstract] [Full Text] [Related]

  • 19. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.
    Olivry T, DeBoer DJ, Favrot C, Jackson HA, Mueller RS, Nuttall T, Prélaud P, International Task Force on Canine Atopic Dermatitis.
    Vet Dermatol; 2010 Jun 07; 21(3):233-48. PubMed ID: 20456716
    [Abstract] [Full Text] [Related]

  • 20. Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial.
    Cadot P, Hensel P, Bensignor E, Hadjaje C, Marignac G, Beco L, Fontaine J, Jamet JF, Georgescu G, Campbell K, Cannon A, Osborn SC, Messinger L, Gogny-Goubert M, Dubreuil P, Moussy A, Hermine O.
    Vet Dermatol; 2011 Dec 07; 22(6):554-64. PubMed ID: 21668810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.